Table 1 The correlation between circ_0072083 level and clinicopathological characteristics in glioma patients
Characteristics | All patients | Relative circ_0072083 level | P value | |
|---|---|---|---|---|
High | Low | |||
Gender | > 0.05 | |||
 Male | 43 | 22 | 21 | |
 Female | 26 | 14 | 12 | |
Age (years) | > 0.05 | |||
  ≥ 50 | 39 | 20 | 19 | |
  < 50 | 30 | 16 | 14 | |
Tumor size (cm) | < 0.05 | |||
  ≥ 4 | 29 | 24 | 5 | |
  < 4 | 40 | 12 | 28 | |
IDH1 | > 0.05 | |||
 Mutation | 33 | 20 | 13 | |
 Wild type | 36 | 16 | 20 | |
WHO grade | < 0.05 | |||
 I-II | 31 | 6 | 25 | |
 III-IV | 38 | 30 | 8 | |
MGMT methylated |  |  |  | < 0.05 |
 Yes | 32 | 6 | 26 | |
 No | 37 | 30 | 7 | |
TMZ-therapy |  |  |  | < 0.05 |
 TMZ-sensitive | 33 | 7 | 26 | |
 TMZ-resistant | 36 | 29 | 7 | |